Hindustan Foods Q1 FY27 Earnings Call — Analysis (NSE: HNDFDS)

Hindustan Foods kicks off FY27 with highest-ever quarterly PAT of ₹42.8 Cr (+33% YoY), reaffirms ₹200-220 Cr PAT guidance, and unveils ₹340 Cr in new project wins, signaling an accelerating capex cycle.

11 Aug 2026 · Analysis by Alpha Inflection

Result quality: stable — Steady quarter. Management sentiment: optimistic.

The take

Q1FY27 Total Income ₹1,207 Cr ( +18% YoY ) . New guidance — FY27 total manufacturing capacity co… exceeding ₹500 Cr . New story: Capex super-cycle with customer underwriting .

Results

Total income ₹1,207 Cr +18% YoY; EBITDA ₹106.3 Cr +26% YoY; PAT ₹42.8 Cr +33% YoY, the highest quarterly PAT despite a ~₹6 Cr footwear cost headwind.

Financial highlights

Guidance

Reaffirmed FY27 PAT guidance of ₹200-220 Cr, representing 34-48% growth over FY26, and expects to commercialize manufacturing capacities exceeding ₹500 Cr during FY27.

What management committed to

• We expect to commercialize manufacturing capacities exceeding ₹500 Cr during FY27. — exceeding ₹500 crores, FY27
• We reaffirm our FY27 PAT guidance of ₹200 Cr to ₹220 Cr. — ₹200 crores to ₹220 crores, FY27
• The footwear division will return to profitability in the coming months. — coming months
• The brownfield expansion at [Silvassa] is expected to commence production during the second quarter [Q2FY27]. — Q2FY27
• The greenfield [Lucknow] facility will be commissioned later this year [by end FY27]. — FY27
• The [Silvassa] facility will be fully operational by the end of August [2026]. — Q2FY27
• We will continue to maintain a 1:1 debt-equity ratio even for these new projects [FY27 capex programme]. — 1:1 debt equity ratio, FY27
• [For footwear] brands have agreed to absorb some of the [raw material/freight] cost increases in the coming season. — coming season

Key themes

Accelerating capex cycle and diversified manufacturing resilience

How the narrative shifted

• Capex super-cycle with customer underwriting: Management positions the record capex pipeline (~₹1,000 Cr in discussions) as evidence of deepening customer partnerships, with many projects on anchor-tenant basis de-risking utilisation.
• Diversified manufacturing resilience: The ability to deliver highest-ever PAT despite footwear headwinds is attributed to the diversified platform; management underscores that 4 of 5 BUs are seeing strong traction.
• Footwear turnaround after multi-quarter drag: After two years of operational consolidation, footwear order book is full from Q2, new customers won, and cost pass-through initiated; management signals confidence that the division will start contributing positively in H2.
• Macro and geopolitical headwinds (Middle East crisis, tariffs, floods): Elevated raw material prices, freight cost spikes due to Middle East tensions, tariff ambiguity delaying U.S. export orders, and a natural disaster at Silvassa are framed as temporary but omnipresent operational risks.
• Structural shift to conversion-only revenue model: Customers increasingly supply raw/packing material due to GST inversion, compressing top-line growth but boosting EBITDA/PAT growth disproportionately; management frames this as a permanent mix shift.
• Export ambitions on hold: Export orders for personal care to the U.S. are ready but stalled by tariff uncertainty; international expansion via EU/U.K. medical device certification and India-U.K. FTA for shoes is in early stages.

Operational commentary

• Home & Personal Care at maximum capacity with record quarterly performance; Aurangabad Personal Care facility integrated and stabilized.
• Food & Beverages: Coimbatore, Nashik, Mysore units at record production; Beverages had an excellent season; adding Greek yogurt facility in Goa.
• Ice Cream: Strong quarter backed by robust summer; Panipat facility commissioned; Nashik adding new customers across ice cream and cones.
• Healthcare: New customers added across syrups, tablets, lozenges; advancing Ayurvedic wellness expansion at Baddi; initiated Class III medical device certification at Chennai for regulated export markets.
• Footwear: New customer wins, order book full from Q2FY27 onwards; temporary cost pressures from Middle East freight/polymer inflation and a one-time Haryana minimum-wage hike (~30% increase).
• Silvassa facility disrupted by record rainfall in July; production partially restored, expected fully operational by end of August; adequately insured.
• Board authorized additional ₹190 Cr investments; total new FY27 projects so far ₹340 Cr (Food & Beverages ₹210 Cr, Ice Cream ₹80 Cr, Home & Personal Care ₹50 Cr).

Analyst Q&A

• Q. Can we negotiate better terms from customers given GST inversion and weakening competition?

  Sameer Kothari: GST inversion is not the cause; but as scale improves and customer base diversifies, profitability and return ratios should improve. We are better placed than some peers.

• Q. Are shoe business headwinds structural? Can pass-through be built into contracts?

  Sameer Kothari: Shoe industry works on fixed seasonal pricing 6-8 months ahead; mid-season changes are not in the industry playbook. We have successfully started passing on costs from this quarter.

• Q. What is the EBITDA and EBIT impact of the shoe business, and what is the ROCE of the shared facility?

  Mayank Samdani: Q1 impact ~₹6 Cr (₹3 Cr labor, rest RM/PM). Sameer Kothari: Shared manufacturing ROCE is below 18% threshold due to shoes but should improve; past is no indication of future.

• Q. Should we expect FY27 PAT towards the lower end of guidance due to footwear stress?

  Sameer Kothari: Too early to say; we reaffirm the ₹200-220 Cr range and will provide granular details if a revision is needed in coming quarters.

• Q. What is the project pipeline and conversion ratio over 3-5 years?

  Sameer Kothari: Current project pipeline is around ₹1,000 Cr in discussions; conversion ratio varies. We will announce only after signing. We will invest internal accruals to maintain 1:1 D/E and grow without outside funds.

View source

Research and educational content only. Not investment advice.